论文部分内容阅读
目的分析该院2014~2015年麻醉性镇痛药的使用情况。方法利用医院信息管理系统收集2014~2015年度麻醉药品的采购数据,采用限定日剂量(DDD)、用药频度(DDDs)、日均费用(DDC)及排序比等评价指标对数据进行统计处理和分析。结果 2015年麻醉药品采购金额明显增长。瑞芬太尼注射剂各年度采购金额位居首位,瑞芬太尼注射剂(1 mg)和芬太尼注射剂(0.1 mg)DDDs呈逐年上升。芬太尼透皮贴剂在临床上广泛应用。临床对羟考酮缓释片使用倾向性较高,各年度使用较为稳定。吗啡制剂在该院使用频率较低。瑞芬太尼注射剂(1 mg)和舒芬太尼注射剂(50μg)DDC较高,分别为202.40元和100.35元。结论该院麻醉药品使用日趋合理,但仍存在不足,需进一步对其使用加强干预和管理。
Objective To analyze the use of narcotic analgesics from 2014 to 2015 in this hospital. Methods The hospital information management system was used to collect the procurement data of narcotic drugs from 2014 to 2015. The data were processed statistically using DDD, DDDs, DDC and sorting ratio. analysis. Results The amount of narcotic drugs procured in 2015 increased significantly. Remifentanil injection ranked first in the annual purchase amount, and the DDDs of remifentanil injection (1 mg) and fentanyl injection (0.1 mg) increased year by year. Fentanyl transdermal patches are widely used clinically. Clinical oxycodone sustained-release tablets use a higher tendency, the use of more stable in each year. Morphine formulations are less frequently used in the hospital. DDC of remifentanil injection (1 mg) and sufentanil injection (50 μg) were higher at 202.40 yuan and 100.35 yuan respectively. Conclusion The use of narcotic drugs in this hospital is becoming more reasonable, but there are still some shortcomings. It is necessary to further strengthen its intervention and management.